Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00080977
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
2004-04-07
Brief Title:
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma Kidney Cancer That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Sponsor:
Blumenthal Cancer Center at Carolinas Medical Center
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2004-04-07
First Submit QC Date:
April 7 2004
Study First Post Date:
2004-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-18
Last Update Post Date:
2013-12-19
Last Update Post Date Type:
ESTIMATED